Intensive Lipid Lowering Therapy among patients with Coronary Artery Disease: a Middle Eastern tertiary care center experience
Keywords:Coronary Artery Disease, Lipid Lowering Therapy
European Association for Cardiovascular Prevention & Rehabilitation, Reiner Z, Catapano AL, De Backer G, et al., ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J, 2011.32(14): p. 1769-818. doi: 10.1093/eurheartj/ehr158.
Stone, N.J., et al., 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation, 2014. 129(25 Suppl 2): p. S1-45. doi: 10.1161/01.cir.0000437738.63853.7a.
PL Detail-Document, Statin Dose Comparison (U.S.). Pharmacist’s Letter/Prescriber’s Letter. May 2012.
Robert S. Rosenson.,et al., Underutilization of High-Intensity Statin Therapy After Hospitalization for Coronary Heart Disease. J Am Coll Cardiol 2015;65:270–7. doi: 10.1016/j.jacc.2014.09.088.
Armitage J. The safety of statins in clinical practice. Lancet 2007;Nov 24;370(9601):1781-90. DOI: http://dx.doi.org/10.1016/S0140-
Bottorff MB. Statin Safety and Drug Interactions: Clinical Implications. Am J Cardiol. 2006 Apr 17;97(8A):27C-31C. DOI: http://dx.doi.org/10.1016/j.amjcard.2005.12.007
Ko DT, Mamdani M, Alter DA. Lipid-lowering therapy with statins in high-risk elderly patients: the treatment–risk paradox. JAMA. 2004; 291: 1864–1870. doi:10.1001/jama.291.15.1864.
Vancheri, F. Trends in coronary heart disease mortality and statin utilization in two European areas with different population risk levels: Stockholm and Sicily. International Cardiovascular Forum Journal. 2014;1:140-146. http://dx.doi.org/10.17987/icfj.v1i3.39
Shewan LG, Coats AJS, Henein M. Requirements for ethical publishing in biomedical journals. International Cardiovascular Forum Journal 2015;2:2 DOI: 10.17987/icfj.v2i1.4
Authors who publish with this journal agree to the following terms:
a. The authors will retain copyright under a Creative Commons Attribution License (CC-BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).